ROLE OF CYTOCHROME P4502E1 IN ALCOHOLIC LIVER-DISEASE PATHOGENESIS

被引:134
|
作者
MORIMOTO, M
HAGBJORK, AL
NANJI, AA
INGELMANSUNDBERG, M
LINDROS, KO
FU, PC
ALBANO, E
FRENCH, SW
机构
[1] UCLA,HARBOR MED CTR,DEPT PATHOL,TORRANCE,CA 90509
[2] KAROLINSKA INST,DEPT PHYSIOL CHEM,S-10401 STOCKHOLM,SWEDEN
[3] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[4] HARVARD UNIV,SCH MED,BOSTON,MA
[5] STATE ALCOHOL MONOPOLY,RES LABS,HELSINKI,FINLAND
[6] UNIV TORINO,DEPT EXPTL MED & ONCOL,TURIN,ITALY
关键词
ALD MODEL; LIPID PEROXIDATION; PUFA; FATTY ACID; LINOLEIC ACID; PROTEIN ADDUCTS; DIALLYL SULFIDE; CYTOCHROME P4502E1;
D O I
10.1016/0741-8329(93)90065-V
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The intragastric tube feeding model is ideal for the study of the role of dietary factors and the effect of drugs on experimental alcoholic liver disease (ALD), since the model allows us to study the effect of a single variable in the diet on the pathology of liver where the blood alcohol level (BAL) is maintained over 150 mg%. By varying the dietary fatty acid composition we showed that the pathology was worsened by increasing linoleic acid or polyunsaturated fatty acids (PUFAs) in the diet where cytochrome P4502E1 (CYP2E1) was increased posttranslationally by high BAL. Concomitant with the increase in CYP2E1 there was evidence for an increase in lipid peroxidation (LP) by microsomes. Protein adducts of the products of LP were increased in the blood. Isoniazid (INH) enhanced this process and the pathology of ALD when INH was fed at therapeutic levels with ethanol. Preliminary studies show that diallyl sulfide, which inhibits and destroys liver CYP2E1 selectively, also modified the pathologic effects of ethanol. Thus we postulate that CYP2E1 induction plays a central role in the pathogenesis of ALD.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 50 条
  • [41] Expression of cytochrome P4502E1 in human liver: Relationship between genotype and phenotype in Chinese
    Wen Tan
    Jianxiong Wu
    Huaijing Tang
    Dongxin Lin
    Science in China Series C: Life Sciences, 2001, 44 : 356 - 364
  • [42] Chlorzoxazone pharmacokinetics as a marker of hepatic cytochrome P4502E1 in humans
    Mishin, VM
    Rosman, AS
    Basu, P
    Kessova, I
    Oneta, CM
    Lieber, CS
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (11): : 2154 - 2161
  • [43] Dilinoleoylphosphatidylcholine decreases ethanol-induced cytochrome P4502E1
    Aleynik, MK
    Lieber, CS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (04) : 1047 - 1051
  • [44] A hypothetical model for the active site of human cytochrome P4502E1
    Tan, YZ
    White, SP
    Paranawithana, SR
    Yang, CS
    XENOBIOTICA, 1997, 27 (03) : 287 - 299
  • [45] Expression of cytochrome P4502E1 in human liver: relationship between genotype and phenotype in Chinese
    谭文
    吴健雄
    唐槐静
    林东昕
    Science in China(Series C:Life Sciences), 2001, (04) : 356 - 364
  • [46] Expression of cytochrome P4502E1 in human liver: relationship between genotype and phenotype in Chinese
    Tan, W
    Wu, JX
    Tang, HJ
    Lin, DX
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2001, 44 (04): : 356 - 364
  • [47] Expression of cytochrome P4502E1 in rat fetal hepatocyte culture
    Wu, DF
    Cederbaum, AI
    MOLECULAR PHARMACOLOGY, 1996, 49 (05) : 802 - 807
  • [48] SELECTIVITY OF CYTOCHROME P4502E1 IN CHLORZOXAZONE 6-HYDROXYLATION
    YAMAZAKI, H
    GUO, ZY
    GUENGERICH, FP
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (03) : 438 - 440
  • [49] PATHOGENESIS OF ALCOHOLIC LIVER-DISEASE
    LAUTERBURG, BH
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 122 (17) : 609 - 613
  • [50] THE PATHOGENESIS OF ALCOHOLIC LIVER-DISEASE
    GOLDIN, R
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1994, 75 (02) : 71 - 78